Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) — Cash Flow Reinvestment Rate
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) has a Cash Flow Reinvestment Rate of 0.39x as of December 2025, reinvesting CN¥711.93 Million (capex CN¥330.65 Million plus investments CN¥381.27 Million) from operating cash flow of CN¥1.84 Billion. See cash generation quality of Guangzhou Baiyunshan Pharmaceutical Hold to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Cash Flow Reinvestment Rate (2000–2025)
Historical reinvestment intensity for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd across 24 annual periods. For the full cash flow conversion analysis, see 600332 cash generation efficiency.
Annual Cash Flow Reinvestment Rate for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (2000–2025)
Year-by-year capital reinvestment analysis for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd. See how financially flexible is Guangzhou Baiyunshan Pharmaceutical Hold to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 12.98x | CN¥3.38 Billion | CN¥260.23 Million | CN¥1.24 Billion | ▲ +649.2% |
| 2024 | 1.73x | CN¥5.96 Billion | CN¥3.44 Billion | CN¥1.13 Billion | ▲ +49.9% |
| 2023 | 1.16x | CN¥4.74 Billion | CN¥4.10 Billion | CN¥1.63 Billion | ▲ +6.2% |
| 2022 | 1.09x | CN¥7.62 Billion | CN¥7.00 Billion | CN¥1.38 Billion | ▲ +375.8% |
| 2021 | 0.23x | CN¥1.30 Billion | CN¥5.67 Billion | CN¥1.25 Billion | ▼ -90.3% |
| 2020 | 2.37x | CN¥1.39 Billion | CN¥585.19 Million | CN¥876.50 Million | ▲ +227.5% |
| 2019 | 0.72x | CN¥3.63 Billion | CN¥5.02 Billion | CN¥2.40 Billion | ▲ +314.7% |
| 2018 | 0.17x | CN¥909.71 Million | CN¥5.22 Billion | CN¥478.62 Million | ▼ -87.5% |
| 2017 | 1.40x | CN¥2.57 Billion | CN¥1.83 Billion | CN¥196.77 Million | ▲ +617.1% |
| 2016 | 0.20x | CN¥477.18 Million | CN¥2.44 Billion | CN¥228.03 Million | ▼ -52.6% |
| 2015 | 0.41x | CN¥800.01 Million | CN¥1.94 Billion | CN¥515.34 Million | ▲ +105.2% |
| 2014 | 0.20x | CN¥353.65 Million | CN¥1.76 Billion | CN¥353.65 Million | ▼ -23.3% |
| 2013 | 0.26x | CN¥350.35 Million | CN¥1.34 Billion | CN¥350.35 Million | ▲ +151.9% |
| 2012 | 0.10x | CN¥52.61 Million | CN¥506.53 Million | CN¥52.61 Million | ▼ -90.9% |
| 2010 | 1.14x | CN¥83.20 Million | CN¥73.17 Million | CN¥83.20 Million | ▲ +470.6% |
| 2009 | 0.20x | CN¥87.56 Million | CN¥439.39 Million | CN¥87.56 Million | ▼ -99.0% |
| 2008 | 20.80x | CN¥126.98 Million | CN¥6.10 Million | CN¥126.98 Million | ▲ +6271.7% |
| 2007 | 0.33x | CN¥122.69 Million | CN¥375.74 Million | CN¥122.69 Million | ▼ -86.0% |
| 2006 | 2.33x | CN¥90.45 Million | CN¥38.88 Million | CN¥90.45 Million | ▲ +173.7% |
| 2005 | 0.85x | CN¥124.36 Million | CN¥146.32 Million | CN¥124.36 Million | ▼ -44.8% |
| 2004 | 1.54x | CN¥308.69 Million | CN¥200.54 Million | CN¥308.69 Million | ▲ +49.8% |
| 2002 | 1.03x | CN¥173.70 Million | CN¥169.01 Million | CN¥173.70 Million | ▼ -10.2% |
| 2001 | 1.14x | CN¥160.44 Million | CN¥140.15 Million | CN¥160.44 Million | ▲ +100.9% |
| 2000 | 0.57x | CN¥163.53 Million | CN¥286.95 Million | CN¥163.53 Million | — |